CAS: 1690-72-8; Methyl 1-Methylpiperidine-3-Carboxylate

该化合物是一种化学化合物,属于硝酸衍生物类别,其特征是,硝酸酸结构氮原子存在一个甲基组,造成其独特的特性.该化合物一般是白色至白色固体,在乙醇和乙醇等有机溶剂中可溶解,但水溶性有限.已知该化合物在药用化学中的潜在应用,特别是在针对...

结构式图片

相似化合物

148763-41-1 88466-76-6 174543-74-9

上下游产品

CAS号63-75-2 槟榔碱 | CAS号50-00-0 甲醛 | CAS号50585-89-2 3-哌啶甲酸甲酯 | CAS号67-56-1 甲醇 | CAS号4685-10-3 Iodonicot | CAS号74-88-4 碘甲烷 | CAS号93-60-7 烟酸甲酯 | CAS号77-78-1 硫酸二甲酯 | CAS号5169-78-8 替培啶

合成工艺路线路线简述

    3-哌啶甲酸置于甲醇,硫酸体系中,用 水 用作溶剂,化学反应 0.25H,反应生成1-甲基-3-哌啶甲酸甲酯
    参考文献: Carboxamide Inhibitors Of Irak4 Activity[fr] Carboxamides Utilisés Comme Inhibiteurs De L'Activité De L'Irak4
    标题: Carboxamide Inhibitors Of Irak4 Activity[fr] Carboxamides Utilisés Comme Inhibiteurs De L'Activité De L'Irak4
    摘要:本发明涉及式(I)的irak4的羧酰胺抑制剂,并提供包含这种抑制剂的组合物,以及用于治疗irak4介导或相关疾病或疾病的方法.

    海关参考信息

    专利信息


    专利号:US-5714466-A
    优先权日:1993-06-22
    标题:Method of using acylation stimulating protein
    发明人:SNIDERMAN ALLAN D; CIANFLONE KATHERINE
    权利人:UNIV MCGILL
    摘要:The present invention relates to a method to determine the amount of ASP protein, a functional derivative or a functional fragment thereof in a plasma sample, wherein the ASP protein comprises the following amino acid sequence: SEQ ID NO: 1 wherein the functional derivative comprises at least one selected from the group consisting of one or more amino acid substitution, one or more amino acid deletion and one or more amino acid addition with the proviso that the functional derivative has a biological activity functionally equivalent to ASP, and the functional fragment comprises part of the ASP amino acid sequence and has a biological activity functionally equivalent to ASP; the method comprises the steps of: a) eluting the plasma sample on a column; b) measuring the amount of the ASP protein, functional derivative or functional fragment thereof present in said sample by an immunoassay with antibodies specific against one or more sites on C3a. The present invention also relates to the use of any antagonist of the ASP protein, functional derivative or functional fragment thereof for the inhibition of triglyceride synthesis in a patient, wherein the antagonist is selected from the group consisting of inhibitors of the alternate complement pathway.

    专利号:US-8703813-B2
    优先权日:2008-10-31
    标题 :Compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
    发明人:Kang heon-joong; RHO JUNG-RAE; HONG JEONG-HO; PARK SEUNG-BUM; SHIN CHAN-SOO; LEE JAE-HWAN; HONG JUN-YOUNG; KIM EUN-O; KIM JEONG-AH; OH SANG-MI
    权利人:Kang heon-joong; RHO JUNG-RAE; HONG JEONG-HO; PARK SEUNG-BUM; SHIN CHAN-SOO; LEE JAE-HWAN; HONG JUN-YOUNG; KIM EUN-O; KIM JEONG-AH; OH SANG-MI; SNU R&DB FOUNDATION
    摘要:Provided is a compound having a spiro chiral carbon backbone, a stereoisomer thereof, an enantiomer thereof, an in vivo hydrolysable precursor thereof, or a pharmaceutically acceptable salt thereof. The compound having the spiro chiral carbon backbone has excellent osteoblast differentiation activity, mast cell inhibitory activity, and fatty acid synthesis inhibitory activity in the liver. Therefore, the compound can be expected to play an innovative role in treatment of osteoporosis, fatty liver, and obesity.
    常州艾坛化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aitanchem.com
    电话: 0086-519-82751350👤
    📞常州艾坛化学有限公司 ⚠️参考联系方式

    销售电话:0086-519-82751350
    邮箱:jwf@hi2000.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Tested as SID 174520223 in AID 781325:
    摘要:Pharmaceutical Chemistry Journal, 17(127), 1983
    摘要:Lawrence, S. A., Science of Synthesis, (2009) 40, 504.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知